Atomistry » Calcium » PDB 3mzo-3ngi » 3n2u
Atomistry »
  Calcium »
    PDB 3mzo-3ngi »
      3n2u »

Calcium in PDB 3n2u: Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide

Enzymatic activity of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide

All present enzymatic activity of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide:
3.4.24.65;

Protein crystallography data

The structure of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide, PDB code: 3n2u was solved by V.Calderone, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.22 / 1.81
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 51.394, 60.446, 54.043, 90.00, 114.67, 90.00
R / Rfree (%) 16.1 / 21.9

Other elements in 3n2u:

The structure of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide also contains other interesting chemical elements:

Zinc (Zn) 2 atoms

Calcium Binding Sites:

The binding sites of Calcium atom in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide (pdb code 3n2u). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide, PDB code: 3n2u:
Jump to Calcium binding site number: 1; 2; 3;

Calcium binding site 1 out of 3 in 3n2u

Go back to Calcium Binding Sites List in 3n2u
Calcium binding site 1 out of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca266

b:16.9
occ:1.00
 O A:GLY190 2.4 11.8 1.0
O A:GLY192 2.4 6.9 1.0
O A:ASP158 2.5 8.2 1.0
O A:HOH320 2.5 24.4 1.0
OD2 A:ASP194 2.6 5.7 1.0
O A:HOH7 2.6 5.2 1.0
CG A:ASP194 3.5 5.8 1.0
C A:ASP158 3.5 8.4 1.0
C A:GLY192 3.6 6.4 1.0
C A:GLY190 3.6 11.8 1.0
OD1 A:ASP194 3.8 6.1 1.0
O A:ALA157 3.8 11.1 1.0
C A:ILE191 3.9 10.0 1.0
N A:GLY192 4.0 8.9 1.0
O A:HOH51 4.1 16.8 1.0
O A:ILE191 4.1 9.9 1.0
CA A:ILE191 4.2 11.5 1.0
CA A:ASP158 4.3 9.3 1.0
N A:ILE191 4.3 10.4 1.0
N A:ASP194 4.4 3.7 1.0
CA A:GLY192 4.4 7.2 1.0
N A:ILE159 4.4 7.2 1.0
O A:GLY188 4.5 11.4 1.0
N A:LEU160 4.6 6.1 1.0
N A:GLY193 4.6 5.8 1.0
CA A:ILE159 4.6 6.2 1.0
CA A:GLY190 4.7 12.4 1.0
N A:GLY190 4.7 11.9 1.0
CB A:ASP194 4.7 4.5 1.0
CA A:GLY193 4.7 5.2 1.0
C A:GLY193 4.8 5.1 1.0
O A:HOH44 4.8 8.3 1.0
C A:ALA157 4.8 11.9 1.0
CA A:ASP194 4.9 5.0 1.0

Calcium binding site 2 out of 3 in 3n2u

Go back to Calcium Binding Sites List in 3n2u
Calcium binding site 2 out of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca267

b:7.0
occ:1.00
 O A:GLU199 2.3 5.1 1.0
OD2 A:ASP124 2.4 8.0 1.0
OE2 A:GLU199 2.4 4.7 1.0
O A:HOH15 2.4 6.7 1.0
O A:GLU201 2.4 7.0 1.0
O A:HOH56 2.5 9.2 1.0
OD1 A:ASP124 2.5 4.5 1.0
CG A:ASP124 2.8 5.1 1.0
C A:GLU199 3.5 6.1 1.0
CD A:GLU199 3.5 5.9 1.0
C A:GLU201 3.6 6.5 1.0
CG A:GLU199 3.9 4.0 1.0
OG1 A:THR122 4.1 4.5 1.0
CA A:GLU199 4.1 5.6 1.0
CA A:PHE202 4.3 7.5 1.0
CB A:ASP124 4.3 6.2 1.0
N A:PHE202 4.4 6.7 1.0
CD1 A:TRP203 4.4 4.3 1.0
N A:GLU201 4.4 6.9 1.0
C A:ASP200 4.5 7.8 1.0
N A:ASP200 4.5 6.5 1.0
OE1 A:GLU199 4.6 5.4 1.0
CB A:GLU199 4.6 6.1 1.0
CA A:GLU201 4.7 7.2 1.0
CA A:ASP200 4.7 7.2 1.0
O A:HOH40 4.8 14.9 1.0
NH2 A:ARG165 4.8 15.2 1.0
N A:TRP203 4.9 6.3 1.0
NE1 A:TRP203 4.9 3.7 1.0
CD1 A:PHE202 4.9 8.0 1.0
O A:ASP200 4.9 8.8 1.0

Calcium binding site 3 out of 3 in 3n2u

Go back to Calcium Binding Sites List in 3n2u
Calcium binding site 3 out of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 3 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor N-Hydroxy-2-(4-Methoxy-N(2-(3,4,5-Trihydroxy-6- (Hydroxymethyl)Tetrahydro-2H-Pyran-2-Yloxy)Ethyl)Phenylsulfonamido) Acetamide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca268

b:11.8
occ:1.00
 O A:GLY176 2.3 12.7 1.0
OD2 A:ASP175 2.3 12.6 1.0
O A:ILE180 2.3 11.2 1.0
OD1 A:ASP198 2.4 7.0 1.0
OE2 A:GLU201 2.4 12.2 1.0
O A:GLY178 2.4 12.1 1.0
CG A:ASP198 3.4 6.2 1.0
C A:GLY176 3.5 12.5 1.0
C A:ILE180 3.5 10.0 1.0
CG A:ASP175 3.5 13.0 1.0
CD A:GLU201 3.6 9.4 1.0
C A:GLY178 3.6 12.5 1.0
N A:GLY178 3.9 13.4 1.0
N A:ILE180 4.0 10.7 1.0
CB A:ASP198 4.1 4.2 1.0
OD1 A:ASP175 4.1 13.8 1.0
C A:LYS177 4.1 14.1 1.0
N A:GLY176 4.2 11.3 1.0
CA A:ILE180 4.3 10.6 1.0
CG A:GLU201 4.3 7.7 1.0
C A:GLY179 4.3 11.3 1.0
C A:ASP175 4.3 10.9 1.0
CA A:GLY178 4.3 13.3 1.0
CA A:LYS177 4.3 14.0 1.0
N A:ASP175 4.3 9.9 1.0
N A:LYS177 4.3 12.3 1.0
OD2 A:ASP198 4.4 6.5 1.0
CA A:GLY176 4.4 11.4 1.0
OE1 A:GLU201 4.5 10.9 1.0
N A:LEU181 4.5 8.1 1.0
N A:GLY179 4.6 12.5 1.0
CA A:LEU181 4.7 7.3 1.0
CA A:ASP175 4.7 10.9 1.0
O A:LYS177 4.7 14.6 1.0
CB A:ASP175 4.7 10.9 1.0
O A:ASP175 4.7 11.2 1.0
CB A:ILE180 4.8 10.6 1.0
CA A:GLY179 4.8 12.2 1.0
O A:GLY179 4.8 11.0 1.0
O A:HOH9 4.9 6.1 1.0

Reference:

E.Attolino, V.Calderone, E.Dragoni, M.Fragai, B.Richichi, C.Luchinat, C.Nativi. Structure-Based Approach to Nanomolar, Water Soluble Matrix Metalloproteinases Inhibitors (Mmpis). Eur.J.Med.Chem. V. 45 5919 2010.
ISSN: ISSN 0223-5234
PubMed: 20965620
DOI: 10.1016/J.EJMECH.2010.09.057
Page generated: Sat Jul 13 14:50:36 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy